Immunohistochemical and in Situ Hybridization Analysis of Galectin-3, a Beta-galactoside Binding Lectin, in the Urinary System of Adult Mice
Overview
Cell Biology
Affiliations
Galectin is an animal lectin that has high affinity to beta-galactoside of glycoconjugates. In the present study, cellular expression of galectin subtypes in the urinary system of adult mice was examined by in situ hybridization and immunohistochemistry. The major subtype expressed in the murine urinary system was galectin-3, which was expressed continuously from the kidney to the distal end of the urethra. The renal cortex expressed galectin-3 more intensely than the medulla. Renal galectin-3 immunoreactivity was strongest in the cortical collecting ducts, where principal cells were the sole cellular source. All cell layers of the transitional epithelium from the renal pelvis to the urethra strongly expressed galectin-3 at the mRNA and protein levels. An electron microscopic study demonstrated diffuse cytoplasmic localization of galectin-3 in principal cells of the collecting ducts and in the bladder epithelial cells. Urethral galectin-3 expression at the pars spongiosa decreased in intensity near the external urethral orifice, where the predominant subtype of galectin was substituted by galectin-7. The muscular layer of the ureter and urinary bladder contained significant signals for galectin-1. Taken together, the observations indicate that the adult urinary system shows intense and selective expression of galectin-3 in epithelia of the uretic bud- and cloaca-derivatives.
Galectin-3 as a Potential Biomarker of Microvascular Complications in Patients with Type 2 Diabetes.
Kumar S, Ranawat C, Bhandiwad C, Arya H, Mali M, Singh C Indian J Endocrinol Metab. 2023; 26(5):490-497.
PMID: 36618522 PMC: 9815198. DOI: 10.4103/ijem.ijem_270_22.
Kumagai Y, Nio-Kobayashi J, Ishihara S, Enomoto A, Akiyama M, Ichihara R Oncogenesis. 2022; 11(1):27.
PMID: 35606369 PMC: 9126940. DOI: 10.1038/s41389-022-00403-9.
Galectin-3 in Kidney Diseases: From an Old Protein to a New Therapeutic Target.
Boutin L, Depret F, Gayat E, Legrand M, Chadjichristos C Int J Mol Sci. 2022; 23(6).
PMID: 35328545 PMC: 8952808. DOI: 10.3390/ijms23063124.
Sung S, Fu S MethodsX. 2020; 7:100935.
PMID: 32577408 PMC: 7303990. DOI: 10.1016/j.mex.2020.100935.
Nie M, Bal M, Liu J, Yang Z, Rivera C, Wu X J Biol Chem. 2018; 293(42):16488-16502.
PMID: 30139743 PMC: 6200953. DOI: 10.1074/jbc.RA118.003950.